Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Gao

Showing results (31-40 of 322) with videos related to

Pageof 33
Sort By:
Drug Discoveries & Therapeutics|June 29, 2025
The pTau217/Aβ<sub>1-42</sub> plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's diseaseShasha Hu, Haizhou Yu, Jianjun Gao
Drug Discoveries & Therapeutics|May 13, 2014
Three-dimensional imaging technology offers promise in medicineKenji Karako, Qiong Wu, Jianjun Gao
BMJ (Clinical Research Ed.)|November 12, 2014
Renal cell carcinomaEric Jonasch, Jianjun Gao, W Kimryn Rathmell
Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Immunotherapy Revolution in Kidney Cancer Treatment: Scientific Rationale and First-Generation ResultsElshad Hasanov, Jianjun Gao, Nizar M Tannir
European Urology|September 14, 2020
Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial CarcinomaAlexander Andreev-Drakhlin, Jianjun Gao, Arlene Siefker-Radtke
Drug Discoveries & Therapeutics|July 12, 2023
Involvement of adaptive immune responses in a model of subacute colitis induced with dextran sulfate sodium in C57BL/6 miceJing Li, Fangzhou Dou, Shasha Hu, et al.
Zootaxa|July 21, 2015
The genus Leucophenga (Diptera, Drosophilidae), part II: the ornata species group from East Asia, with morphological and molecular evidence (I)Jia Huang, Li Tong, Jianjun Gao, et al.
Natural Product Research|August 4, 2005
Iridoid glucosides from Viburnum sargentiLamberto Tomassini, Jianjun Gao, Mauro Serafini, et al.
Carcinogenesis|November 4, 2005
NO-donating aspirin induces phase II enzymes in vitro and in vivoJianjun Gao, Khosrow Kashfi, Xiaoping Liu, et al.
Intractable & Rare Diseases Research|October 25, 2014
New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical applicationPeipei Song, Jianjun Gao, Norihiro Kokudo, et al.
Pageof 33

Showing results (31-40 of 322) with videos related to

Sort By:
Pageof 33
Drug Discoveries & Therapeutics|June 29, 2025
The pTau217/Aβ<sub>1-42</sub> plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's diseaseShasha Hu, Haizhou Yu, Jianjun Gao
Drug Discoveries & Therapeutics|May 13, 2014
Three-dimensional imaging technology offers promise in medicineKenji Karako, Qiong Wu, Jianjun Gao
BMJ (Clinical Research Ed.)|November 12, 2014
Renal cell carcinomaEric Jonasch, Jianjun Gao, W Kimryn Rathmell
Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Immunotherapy Revolution in Kidney Cancer Treatment: Scientific Rationale and First-Generation ResultsElshad Hasanov, Jianjun Gao, Nizar M Tannir
European Urology|September 14, 2020
Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial CarcinomaAlexander Andreev-Drakhlin, Jianjun Gao, Arlene Siefker-Radtke
Drug Discoveries & Therapeutics|July 12, 2023
Involvement of adaptive immune responses in a model of subacute colitis induced with dextran sulfate sodium in C57BL/6 miceJing Li, Fangzhou Dou, Shasha Hu, et al.
Zootaxa|July 21, 2015
The genus Leucophenga (Diptera, Drosophilidae), part II: the ornata species group from East Asia, with morphological and molecular evidence (I)Jia Huang, Li Tong, Jianjun Gao, et al.
Natural Product Research|August 4, 2005
Iridoid glucosides from Viburnum sargentiLamberto Tomassini, Jianjun Gao, Mauro Serafini, et al.
Carcinogenesis|November 4, 2005
NO-donating aspirin induces phase II enzymes in vitro and in vivoJianjun Gao, Khosrow Kashfi, Xiaoping Liu, et al.
Intractable & Rare Diseases Research|October 25, 2014
New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical applicationPeipei Song, Jianjun Gao, Norihiro Kokudo, et al.
Pageof 33